Molecular Templates, Inc. (MTEM): Price and Financial Metrics

Molecular Templates, Inc. (MTEM): $0.35

0.01 (+3.95%)

POWR Rating

Component Grades













MTEM Stock Summary

  • MTEM has a market capitalization of $18,314,285 -- more than approximately just 7.98% of US stocks.
  • The capital turnover (annual revenue relative to shareholder's equity) for MTEM is 8.46 -- better than 95.69% of US stocks.
  • Of note is the ratio of MOLECULAR TEMPLATES INC's sales and general administrative expense to its total operating expenses; merely 10.75% of US stocks have a lower such ratio.
  • Stocks that are quantitatively similar to MTEM, based on their financial statements, market capitalization, and price volatility, are CTMX, SELB, SIMO, CRUS, and IMTX.
  • MTEM's SEC filings can be seen here. And to visit MOLECULAR TEMPLATES INC's official web site, go to

MTEM Valuation Summary

  • In comparison to the median Healthcare stock, MTEM's EV/EBIT ratio is 109.16% lower, now standing at -0.6.
  • MTEM's price/sales ratio has moved NA NA over the prior 220 months.

Below are key valuation metrics over time for MTEM.

Stock Date P/S P/B P/E EV/EBIT
MTEM 2023-03-17 0.5 4.4 -0.2 -0.6
MTEM 2023-03-16 0.5 4.6 -0.2 -0.6
MTEM 2023-03-15 0.5 4.5 -0.2 -0.6
MTEM 2023-03-14 0.6 4.8 -0.2 -0.6
MTEM 2023-03-13 0.6 4.8 -0.2 -0.6
MTEM 2023-03-10 0.8 6.9 -0.4 -0.7

MTEM Growth Metrics

    Its 2 year cash and equivalents growth rate is now at -43.18%.
  • The 3 year net cashflow from operations growth rate now stands at -1453.07%.
  • The 4 year cash and equivalents growth rate now stands at 201.14%.
Over the past 49 months, MTEM's revenue has gone up $25,686,000.

The table below shows MTEM's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 35.107 -93.053 -80.912
2022-06-30 33.246 -93.436 -86.661
2022-03-31 43.963 -100.297 -77.842
2021-12-31 38.697 -30.387 -83.009
2021-09-30 24.23 -29.432 -101.211
2021-06-30 26.149 -24.44 -94.049

MTEM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MTEM has a Quality Grade of C, ranking ahead of 37.75% of graded US stocks.
  • MTEM's asset turnover comes in at 0.13 -- ranking 237th of 681 Pharmaceutical Products stocks.
  • AGEN, ARDX, and LGND are the stocks whose asset turnover ratios are most correlated with MTEM.

The table below shows MTEM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.130 1 -0.688
2021-03-31 0.102 1 -1.004
2020-12-31 0.123 1 -0.976
2020-09-30 0.133 1 -0.940
2020-06-30 0.146 1 -1.283
2020-03-31 0.139 1 -1.005

MTEM Price Target

For more insight on analysts targets of MTEM, see our MTEM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $13.43 Average Broker Recommendation 1.33 (Strong Buy)

MTEM Stock Price Chart Interactive Chart >

Price chart for MTEM

MTEM Price/Volume Stats

Current price $0.35 52-week high $3.64
Prev. close $0.34 52-week low $0.31
Day low $0.33 Volume 334,500
Day high $0.38 Avg. volume 857,720
50-day MA $0.47 Dividend yield N/A
200-day MA $0.66 Market Cap 19.72M

Molecular Templates, Inc. (MTEM) Company Bio

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is based in Austin, Texas.

MTEM Latest News Stream

Event/Time News Detail
Loading, please wait...

MTEM Latest Social Stream

Loading social stream, please wait...

View Full MTEM Social Stream

Latest MTEM News From Around the Web

Below are the latest news stories about MOLECULAR TEMPLATES INC that investors may wish to consider to help them evaluate MTEM as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting the final day of the week with a breakdown of the biggest pre-market stock movers worth watching on Friday!

William White on InvestorPlace | March 10, 2023

Why Is Allbirds (BIRD) Stock Down 25% Today?

Allbirds (BIRD) stock is falling hard on Friday following the release of its earnings report for the fourth quarter of 2022.

William White on InvestorPlace | March 10, 2023

Why Is Barnes & Noble Education (BNED) Stock Up 20% Today?

Barnes & Noble Education (BNED) stock is climbing higher on Friday following the release of its earnings report for fiscal Q3 2023.

William White on InvestorPlace | March 10, 2023

Why Is Molecular Templates (MTEM) Stock Up 36% Today?

Molecular Templates (MTEM) stock is rocketing higher on Friday after the company got approval from the FDA for a clinical trial.

William White on InvestorPlace | March 10, 2023

Why Is SVB Financial (SIVB) Stock Down 44% Today?

SVB Financial (SIVB) stock continues to fall on Friday after the company revealed plans for a public offering to raise funds.

William White on InvestorPlace | March 10, 2023

Read More 'MTEM' Stories Here

MTEM Price Returns

1-mo N/A
3-mo -0.51%
6-mo -50.47%
1-year -86.38%
3-year -97.31%
5-year -96.18%
YTD 6.71%
2022 -91.63%
2021 -58.25%
2020 -32.86%
2019 246.16%
2018 -59.68%

Continue Researching MTEM

Want to see what other sources are saying about Molecular Templates Inc's financials and stock price? Try the links below:

Molecular Templates Inc (MTEM) Stock Price | Nasdaq
Molecular Templates Inc (MTEM) Stock Quote, History and News - Yahoo Finance
Molecular Templates Inc (MTEM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.828 seconds.